Aspire Private Capital, LLC Pfizer Inc Transaction History

Aspire Private Capital, LLC

$385 Million
Q2 2024

A detailed history of Aspire Private Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aspire Private Capital, LLC holds 2,751 shares of PFE stock, worth $81,594. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,751

Previous 2,843 3.24%

Holding current value

$81,594

Previous $78,000 2.56%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $2,323 - $2,723	-92 Reduced 3.24%	2,751 $76,000
Q1 2024 Apr 18, 2024	BUY	$25.89 - $29.73 $5,436 - $6,243	210 Added 7.98%	2,843 $78,000
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $3,475 - $4,514	-133 Reduced 4.81%	2,633 $75,000
Q3 2023 Nov 03, 2023	BUY	$32.09 - $37.51 $2,920 - $3,413	91 Added 3.4%	2,766 $91,000
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $1,480 - $1,713	-41 Reduced 1.51%	2,675 $98,000
Q1 2023 May 30, 2023	SELL	$39.39 - $51.28 $9,453 - $12,307	-240 Reduced 8.12%	2,716 $110,000
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $9,453 - $12,307	-240 Reduced 8.12%	2,716 $110,000
Q4 2022 May 30, 2023	BUY	$41.75 - $54.5 $10,020 - $13,080	240 Added 8.84%	2,956 $151,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $4,175 - $5,450	-100 Reduced 3.27%	2,956 $151,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $5,513 - $6,730	-126 Reduced 3.96%	3,056 $134,000
Q2 2022 Aug 01, 2022	SELL	$46.53 - $55.17 $2,373 - $2,813	-51 Reduced 1.58%	3,182 $167,000
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $32,299 - $40,023	-706 Reduced 17.92%	3,233 $167,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $27,188 - $40,302	-658 Reduced 14.31%	3,939 $233,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $18,447 - $23,697	-470 Reduced 9.28%	4,597 $198,000
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $183,823 - $208,240	-5,119 Reduced 50.26%	5,067 $198,000
Q1 2021 May 26, 2021	SELL	$33.49 - $37.77 $186,170 - $209,963	-5,559 Reduced 35.31%	10,186 $369,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $6,225 - $7,916	-186 Reduced 1.17%	15,745 $580,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $8,064 - $9,461	-254 Reduced 1.57%	15,931 $585,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $7,620 - $9,244	253 Added 1.59%	16,185 $529,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $100,443 - $143,511	-3,716 Reduced 18.91%	15,932 $520,000
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $250,751 - $284,571	7,617 Added 63.31%	19,648 $770,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $212,094 - $275,024	6,528 Added 118.63%	12,031 $432,000
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $90,600 - $101,724	2,450 Added 80.25%	5,503 $238,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $4,200 - $4,614	-112 Reduced 3.54%	3,053 $130,000
Q4 2018 Feb 25, 2019	BUY	$38.47 - $43.86 $109,562 - $124,913	2,848 Added 898.42%	3,165 $138,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $12,194 - $13,903	317 New	317 $138,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.

Account

Aspire Private Capital, LLC Pfizer Inc Transaction History